The influence of lamivudine, stavudine and nevirapine on the pharmacokinetics of chlorpropamide in human subjects

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 33, Issue 3, 2008, Pages 165-171

  Bakare Odunola, M T ^a   Enemali, I ^a   Garba, M ^a   Obodozie, O O ^b   Mustapha, K B ^b  

^a ABU   (Nigeria)

^b NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

Author keywords

Chlorpropamide; Lamivudine; Nevirapine; Pharmacokinetics; Stavudine

Indexed keywords

ANTIDIABETIC AGENT; ANTIRETROVIRUS AGENT; CHLORPROPAMIDE; GLUCOSE OXIDASE; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DIABETIC PATIENT; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MAXIMUM PLASMA CONCENTRATION; PATIENT CARE;

EID: 56249139382     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03191114     Document Type: Article

References (12)

1. Yoon J.G. (1979): Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med., 300, 1173-1179.
2. Srinkata S., Ganda C.P., Jackson R.A., Gleason R.E., Kaldany A., Gorovoy M.R., Milford E.L., Carpenter C.B., Soeldner J.S., Eisenbarth G.S. (1983): Type 1 diabetes mellitus in monozygotic twins: chronic progression β-cell dysfunction. J. Ann. Intern. Med., 99, 320-326.
3. Fajan S.S. (1988): Current unsolved problems in diabetes management. Diabetes, 21, 678-684.
4. Barry M., Mulcaly F., Merry C., Gibbons S., Back D. (1999): Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin. Pharmacokinet., 36, 289.
5. Highleyman L. (2005): Drug interactions in the management of HIV infection. In: Bulletin of Experimental Treatments for AIDS (BETA). Publication of San Francisco AIDS Foundation, 17, 20-29.
6. Scheen A.J., Lefebvre P.J. (1995): Antihyperglycemic agents: drug interactions of clinical importance. Drug safety, 12, 32-45.
7. Back D. (2003): Pharmacokinetic drug interactions with nevirapine. J. Acquired immune Def. Syndr. (JAIDS), 34, S8-S14.
8. Bakare M.T., Mustapha A., Abdu-Aguye I. (1994): An improved high-performance liquid chromatographic determination of chlorpropamide in human plasma. Chromatography, 39, 107-109.
9. Seltzer H.S. (1989): Drug-induced hyperglycemia. A review of 1418 cases. J. Endocrin. Metab. North America, 18, 163-168.
10. Sepkowitz K.A. (2001): AIDS - the first 20 years. N. Engl. J. Med., 344, 1764-1772.
11. Cheryn P. (2003): Treatment and highly active antiretroviral therapy. Austral. Prescrib., 26, 56-61.
12. Bakare-Odunola M.T., Mustapha A., Yakasai I.A., Garba M. (2002): Effect of Nigerian meals on the pharmacokinetics of chlorpropamide in healthy subjects. Niger. J. Pharm. Res., 1, 51-53.